ASX:TLXPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Telix Pharmaceuticals Ltd
$17.380
+$0.540 (+3.21%)
Day Range
$16.550 – $18.130
52 Week Range
$8.260 – $19.070
Volume
5.21M
Avg Volume (10D)
1.63M
Market Cap
$5.91B
Price Chart
OHLC · volume · moving averages
$17.380+$7.770 (+80.85%)over 6M
Hi$18.130Lo$9.000Avg Vol2.3M
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$17.150
Previous Close
$16.840
Day High
$18.130
Day Low
$16.550
52 Week High
$19.070
52 Week Low
$8.260
Valuation
Fundamental multiples
Market Cap
5.91B
Shares Outstanding
339.78M
Price to Book
9.71
Trading Activity
Volume & order book
Volume
5.21M
Value Traded
90.40M
Bid
$17.200 × 1,500
Ask
$17.450 × 15,000
Performance
Returns across timeframes
1 Day
1.88%
5 Day
-1.12%
13 Week
17.95%
52 Week
-5.52%
YTD
49.64%
Technical Indicators
Momentum & moving averages
RSI (14)
65.60
50-Day SMA
$15.584
200-Day SMA
$13.325
— From the desk
Latest News
Hot Topics
ASX Weekly Wrap: Narrow Leadership, Sticky Core Inflation & Weak Aussie
ASX 200 near 8,764 as Judo Capital dives 39% on funding-cost fears; week capped by hawkish Fed, sticky core inflation and volatile leadership.
Biotechnology
Five New Stocks For The Healthcare Sector Rotation: PME, TLX, TNE, 360, and SDR
ASX healthcare rotation heats up as PME, TLX, TNE, 360, SDR emerge—five stocks positioned to ride the sector shift amid oil, inflation and volatility.
Hot Topics
SmallCaps Weekly Wrap & New Fundie Picks
Hot Topics
Weekly Wrap: Strong Week Despite Late Fade
ASX up 4.4% for the week; strongest since Oct 2022, despite Friday fade. Magellan-Barrenjoey merger approved; Telix jumps on US regulator nod; Iran talks ahead.